Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by FredTheVoiceon Oct 12, 2018 11:34am
168 Views
Post# 28788586

Like in all good family

Like in all good family So many things we dont know in the small day to day of running a business.

I was wondering. Lyne's departure is maybe exactly the proof of a good move from the management. Who knows......accumulations of tensions in the house, pressure on her, pressure from her, "listen Lyne, thanks for the good job done, we are looking for new blood with all whats coming". EUROPE, new products.....

So many times I heard and was witness of some inside moves, pressure, and reorganisation.

Sometimes, CEO sits with a director and "I think its time to leave....lets do it all together for the best of TH, yourself and the future.....".

What we all know besides, the fondamentals for TH are the same (TH is profitable right now, so its a bad move for Lyne to sell now.........so ther is something behind......frustration ?).

We are living (short term) a small stock price depression.

But the future is bright. And the person who will replace Lyne, will buy some shares, and HEY, maybe he will keep them for a couple of years........(this one is for PALINC....: maybe he will buy as much shares that TH will deliver him OPTIONS....).

FTV. 
Bullboard Posts